BioNTech SE Detailed Financials
Full historical quarterly statements
| Metric | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 120.0M | 898.9M | 1.52B | 260.8M | 182.8M | 1.19B | 1.24B | 128.7M |
| Cost of Goods Sold | 195.9M | 330.2M | 148.3M | 76.4M | 83.8M | 243.5M | 178.9M | 59.8M |
| Gross Profit | -75.8M | 568.7M | 1.37B | 184.4M | 99.0M | 946.5M | 1.07B | 68.9M |
| R&D Expenses | 566.2M | 500.7M | 564.8M | 509.1M | 525.6M | 611.8M | 550.3M | 584.6M |
| Operating Expenses | 596.1M | 799.3M | 1.42B | 685.5M | 633.1M | 797.9M | 1.06B | 1.04B |
| Operating Income | -672.0M | -230.6M | -46.9M | -501.1M | -534.1M | 148.6M | 10.5M | -966.2M |
| Other Income / Gains | 94.5M | 5.3M | 71.6M | 98.4M | 88.7M | 152.6M | 148.2M | 160.4M |
| Net Income | -540.6M | -302.1M | -28.7M | -386.6M | -415.8M | 259.5M | 198.1M | -807.8M |
| EPS (Diluted) | -2.14 | -1.23 | -0.12 | -1.60 | -1.73 | 1.08 | 0.83 | -3.42 |
| Reported Currency | EUR | EUR | EUR | EUR | EUR | EUR | EUR | EUR |
| Gross Profit Ratio | -0.632 | 0.633 | 0.902 | 0.707 | 0.542 | 0.795 | 0.856 | 0.535 |
| General And Administrative Expenses | 0 | 242.4M | 121.2M | 117.7M | 106.9M | 110.8M | 132.4M | 170.9M |
| Selling And Marketing Expenses | 0 | 49.3M | 27.3M | 19.7M | 13.7M | 21.3M | 18.1M | 12.9M |
| Selling General And Administrative Expenses | 30.0M | 291.7M | 148.5M | 137.4M | 120.6M | 132.1M | 150.5M | 183.8M |
| Other Expenses | 0 | 7.0M | 704.2M | 39.0M | -13.1M | 54.0M | 354.6M | 266.7M |
| Cost And Expenses | 792.0M | 1.13B | 1.57B | 761.9M | 716.9M | 1.04B | 1.23B | 1.09B |
| Interest Income | 62.7M | 260.1M | 0 | 0 | 0 | 0 | 0 | 168.2M |
| Interest Expense | 4.1M | 6.4M | 399K | 3.3M | 6.2M | 0 | 5.2M | 7.3M |
| Depreciation And Amortization | 123.3M | 163.3M | 124.2M | 51.0M | 42.8M | 165.4M | 44.4M | 49.9M |
| Ebitda | -548.7M | -67.4M | 149.3M | -348.3M | -368.7M | 464.4M | 211.1M | -752.5M |
| Ebitdaratio | -4.571 | -0.075 | 0.098 | -1.336 | -2.017 | 0.39 | 0.17 | -5.847 |
| Operating Income Ratio | -5.598 | -0.257 | -0.031 | -1.921 | -2.922 | 0.125 | 0.008 | -7.507 |
| Income Before Tax | -577.4M | -225.3M | 24.7M | -402.7M | -445.4M | 301.2M | 158.7M | -805.8M |
| Income Before Tax Ratio | -4.81 | -0.251 | 0.016 | -1.544 | -2.437 | 0.253 | 0.127 | -6.261 |
| Income Tax Expense | -36.8M | 76.9M | 53.4M | -16.1M | -29.6M | 41.7M | -39.4M | 2.0M |
| Net Income Ratio | -4.504 | -0.336 | -0.019 | -1.482 | -2.275 | 0.218 | 0.159 | -6.277 |
| Epsdiluted | -2.14 | -1.23 | -0.12 | -1.60 | -1.73 | 1.08 | 0.81 | -3.42 |
| Weighted Average Shs Out | 252.9M | 245.2M | 239.2M | 241.6M | 240.3M | 240.3M | 239.7M | 237.7M |
| Weighted Average Shs Out Dil | 252.9M | 245.2M | 239.2M | 241.6M | 240.3M | 240.3M | 244.6M | 237.7M |